Mike Mitka. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Agents/therapeutic useClinical Trials, Phase IV as TopicDrug ApprovalGefitinibQuinazolines/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Antineoplastic AgentsQuinazolinesGefitinib
Year: 2003 PMID: 12824196 DOI: 10.1001/jama.289.24.3227
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272